Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 17, 2022

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR INSULATARD NPH HUMAN

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for Insulatard Nph Human

Subscribe to access the full database, or Try it Free
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00346996 ↗	Insulin Analogues and Severe Hypoglycaemia	Completed	Novo Nordisk A/S	Phase 4	2007-05-01	Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00346996 ↗	Insulin Analogues and Severe Hypoglycaemia	Completed	Lise Tarnow	Phase 4	2007-05-01	Severe hypoglycaemia is hampering the lives of many diabetic patients. The effect on the occurrence of severe hypoglycaemia during two different insulin regimens are to be investigated. In total, 250 hypoglycaemia prone type 1 diabetic patients will be randomised to receive analogue and human insulin for one year in random order. Outcomes will be number of episodes of severe hypoglycaemia
NCT00566124 ↗	Basal Insulins - Pharmacodynamics	Completed	Novo Nordisk A/S	Phase 4	2005-01-01	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
NCT00566124 ↗	Basal Insulins - Pharmacodynamics	Completed	The Danish Diabetes Association	Phase 4	2005-01-01	To purpose of this study is to compare the pharmacodynamic properties of insulin detemir, insulin glargine and NPH insulin after a single subcutaneous injection.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Insulatard Nph Human

Condition Name

Chart
Table

Condition Name for Insulatard Nph Human
Intervention	Trials
Diabetes	7
Diabetes Mellitus, Type 2	4
Type 1 Diabetes	2
Diabetes Mellitus, Type 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Insulatard Nph Human
Intervention	Trials
Diabetes Mellitus	8
Diabetes Mellitus, Type 2	6
Diabetes Mellitus, Type 1	4
Hyperglycemia	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Insulatard Nph Human

Trials by Country

Map
Table

Trials by Country for Insulatard Nph Human
Location	Trials
Denmark	3
Germany	2
Romania	1
Austria	1
Hungary	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Insulatard Nph Human

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Insulatard Nph Human
Clinical Trial Phase	Trials
Phase 4	5
Phase 2	1
Phase 1	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Insulatard Nph Human
Clinical Trial Phase	Trials
Completed	11
Unknown status	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Insulatard Nph Human

Sponsor Name

Chart
Table

Sponsor Name for Insulatard Nph Human
Sponsor	Trials
Novo Nordisk A/S	8
The Danish Diabetes Association	1
The Institute of Experimental Clinical Research, University of Aarhus	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Insulatard Nph Human
Sponsor	Trials
Other	10
Industry	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Baxter

Dow

AstraZeneca

Moodys

McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.